Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lu Alleruzzo"'
Autor:
Ashley R. Hoover, Sunil More, Kaili Liu, Connor L. West, Trisha I. Valerio, Coline L. Furrer, Ningli Yu, Crystal Villalva, Amit Kumar, Lu Alleruzzo, Samuel S. K. Lam, Tomas Hode, Meng Zhao, James F. Papin, Wei R. Chen
Mucosal vaccinations for respiratory pathogens provide effective protection as they stimulate localized cellular and humoral immunities at the site of infection. Currently, the major limitation of intranasal vaccination is using effective adjuvants c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c7ff3e78f2032c2cb76dff6f32ccc38
https://doi.org/10.1101/2022.09.07.506979
https://doi.org/10.1101/2022.09.07.506979
Autor:
Ashley R. Hoover, Kaili Liu, Samuel Siu Kit Lam, Chun Fung Wong, Alexandra D. Medcalf, Xiao-Hong Sun, Tomas Hode, Lu Alleruzzo, Coline Furrer, Trisha I. Valerio, Wei R. Chen
N-dihydrogalactochitosan (GC) is developed for inducing immune responses. Synthesized from chitosan and galactose, GC is a new chemical entity that significantly enhances the immune-stimulating properties of its parental material, chitosan, making it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65fa4f38096de0cd547056b4a7bebffb
https://doi.org/10.1101/2022.07.22.501157
https://doi.org/10.1101/2022.07.22.501157
Autor:
Xiaosong Li, Wei R. Chen, Feifan Zhou, Lu Alleruzzo, Mark F. Naylor, Joseph Raker, Siu Kit Lam, Tomas Hode
Publikováno v:
SPIE Proceedings.
Immunologically oriented therapy (immunotherapy) has arguably proved to be the most effective method for treating advanced melanoma, the prototypical chemotherapy-resistant solid tumor. The efficacy and benefit of immunotherapy for other tumors, incl
Autor:
Xiaoqiang, Qi, Samuel Sk, Lam, Dai, Liu, Dae Young, Kim, Lixin, Ma, Lu, Alleruzzo, Wei, Chen, Tomas, Hode, Carolyn J, Henry, Jussuf, Kaifi, Eric T, Kimchi, Guangfu, Li, Kevin F, Staveley-O'Carroll
Publikováno v:
Journal of clinical & cellular immunology
Manipulation of immune system toward the rejection of established cancers has become the standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (H
Autor:
Kevin F. Staveley-O’Carroll, Lu Alleruzzo, Dai Liu, Xiaoqiang Qi, Samuel Sk Lam, Dae Young Kim, Jussuf T. Kaifi, Guangfu Li, Lixin Ma, Carolyn J. Henry, Wei R. Chen, Eric T. Kimchi, Tomas Hode
Publikováno v:
Journal of Clinical & Cellular Immunology. 7
Manipulation of immune system toward the rejection of established cancers has become the standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (H